CD8A and neuroblastoma: Our study reveals that EDF1-induced GD3 synthesis through the RelA/ST8SIA1 axis in NB cells predominantly contribute to its suppressive effect on CD8+ T cells, highlighting its potential as an immunotherapeutic regulator.